355 related articles for article (PubMed ID: 30222595)
21. Dual Versus Triple Antithrombotic Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: An Updated Meta-Analysis.
Goel S; Pasam RT; Sharma A; Gidwani U
Cardiovasc Revasc Med; 2020 Feb; 21(2):239-241. PubMed ID: 31718958
[No Abstract] [Full Text] [Related]
22. Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents: The LF II Study.
Krucoff MW; Urban P; Tanguay JF; McAndrew T; Zhang Y; Rao SV; Morice MC; Price MJ; Cohen DJ; Abdel-Wahab M; Mehta SR; Faurie B; McLaurin B; Diaz C; Stoll HP; Pocock S; Leon MB
Circ Cardiovasc Interv; 2020 Apr; 13(4):e008603. PubMed ID: 32279567
[TBL] [Abstract][Full Text] [Related]
23. Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary intervention.
Wustrow I; Sarafoff N; Haller B; Rössner L; Sibbing D; Schüpke S; Ibrahim T; Anetsberger A; Schunkert H; Laugwitz KL; Kastrati A; Bernlochner I
Catheter Cardiovasc Interv; 2018 Dec; 92(7):1239-1246. PubMed ID: 30019824
[TBL] [Abstract][Full Text] [Related]
24. Is there a Role for Oral Triple Therapy in Patients with Acute Coronary Syndromes Without Atrial Fibrillation?
Spinthakis N; Farag M; Akhtar Z; Gorog DA
Curr Vasc Pharmacol; 2018; 16(5):427-436. PubMed ID: 29345587
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Outcomes Evaluation After Percutaneous Coronary Intervention in Stable Ischemic Heart Disease and Acute Coronary Syndrome for Short- Versus Standard-Term Dual Antiplatelet Therapy: A Systematic Review and Meta-analysis of Randomized Control Trials.
Bhattarai M; Ibrahim AM; Salih M; Tandan N; Al-Akchar M; Ayan M; Kulkarni A; Hafiz AM
J Cardiovasc Pharmacol; 2020 Nov; 76(5):574-583. PubMed ID: 33165135
[TBL] [Abstract][Full Text] [Related]
26. Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. A meta-analysis.
Chen CF; Chen B; Zhu J; Xu YZ
Herz; 2015 Dec; 40(8):1070-83. PubMed ID: 26135462
[TBL] [Abstract][Full Text] [Related]
27. Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.
Xanthopoulou I; Dragona VM; Davlouros P; Tsioufis C; Iliodromitis E; Alexopoulos D;
Cardiovasc Drugs Ther; 2018 Apr; 32(2):191-196. PubMed ID: 29679301
[TBL] [Abstract][Full Text] [Related]
28. Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients.
Galli M; Andreotti F; Porto I; Crea F
Europace; 2020 Apr; 22(4):538-546. PubMed ID: 31942971
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
[TBL] [Abstract][Full Text] [Related]
30. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U
Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144
[TBL] [Abstract][Full Text] [Related]
31. Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies.
Yoshikawa Y; Shiomi H; Watanabe H; Natsuaki M; Kondo H; Tamura T; Nakagawa Y; Morimoto T; Kimura T
Circulation; 2018 Feb; 137(6):551-562. PubMed ID: 28982692
[TBL] [Abstract][Full Text] [Related]
32. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
[TBL] [Abstract][Full Text] [Related]
33. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL;
JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257
[TBL] [Abstract][Full Text] [Related]
34. The efficacy and safety of P2Y12 inhibitor monotherapy in patients after percutaneous coronary intervention.
Luo L; Fu M; Li Y; Chen Z; Yu J; Luo J; Hu S; Tu L; Xu X
Clin Cardiol; 2020 Mar; 43(3):235-241. PubMed ID: 31777973
[TBL] [Abstract][Full Text] [Related]
35. The safety and efficacy of oral anticoagulants with dual versus single antiplatelet therapy in patients after percutaneous coronary intervention: A meta-analysis.
Chen J; Wang LY; Deng C; Jiang XH; Chen TG
Medicine (Baltimore); 2017 Sep; 96(37):e8015. PubMed ID: 28906384
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting.
Rubboli A; Milandri M; Castelvetri C; Cosmi B
Cardiology; 2005; 104(2):101-6. PubMed ID: 16020950
[TBL] [Abstract][Full Text] [Related]
37. Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
Baber U; Chandrasekhar J; Sartori S; Aquino M; Kini AS; Kapadia S; Weintraub W; Muhlestein JB; Vogel B; Faggioni M; Farhan S; Weiss S; Strauss C; Toma C; DeFranco A; Baker BA; Keller S; Effron MB; Henry TD; Rao S; Pocock S; Dangas G; Mehran R
JACC Cardiovasc Interv; 2017 Oct; 10(20):2017-2025. PubMed ID: 28780028
[TBL] [Abstract][Full Text] [Related]
38. Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Galli M; Benenati S; Capodanno D; Franchi F; Rollini F; D'Amario D; Porto I; Angiolillo DJ
Lancet; 2021 Apr; 397(10283):1470-1483. PubMed ID: 33865495
[TBL] [Abstract][Full Text] [Related]
39. Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis.
Saglietto A; D'Ascenzo F; Errigo D; Leonardi S; Dewilde WJ; Conrotto F; Omedè P; Montefusco A; Angelini F; De Filippo O; Bianco M; Gallone G; Bruno F; Zaccaro L; Giannini F; Latib A; Colombo A; Costa F; De Ferrari GM
Catheter Cardiovasc Interv; 2021 Mar; 97(4):581-588. PubMed ID: 32790145
[TBL] [Abstract][Full Text] [Related]
40. Omission of aspirin in patients taking oral anticoagulation after percutaneous coronary intervention: a systematic review and meta-analysis.
Zhang J; Wang Z; Sang W; Wei M; Xu F; Chen Y
Coron Artery Dis; 2019 Mar; 30(2):109-115. PubMed ID: 30629002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
